Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Decrease in Short Interest

Sensus Healthcare, Inc. (NASDAQ:SRTS) was the recipient of a large decrease in short interest in February. As of February 15th, there was short interest totalling 1,180,000 shares, a decrease of 23.9% from the January 31st total of 1,550,000 shares. Based on an average daily trading volume, of 335,000 shares, the days-to-cover ratio is presently 3.5 days. Approximately 8.8% of the shares of the stock are sold short.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Maxim Group upped their price target on shares of Sensus Healthcare from $12.00 to $14.00 and gave the company a “buy” rating in a report on Friday, November 15th. HC Wainwright lifted their price objective on Sensus Healthcare from $11.00 to $12.00 and gave the company a “buy” rating in a report on Monday, February 10th. Finally, Lake Street Capital began coverage on Sensus Healthcare in a research report on Friday, January 31st. They set a “buy” rating and a $18.00 target price on the stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Squarepoint Ops LLC increased its position in shares of Sensus Healthcare by 175.5% during the fourth quarter. Squarepoint Ops LLC now owns 85,677 shares of the company’s stock worth $593,000 after acquiring an additional 54,576 shares during the period. Man Group plc grew its position in Sensus Healthcare by 34.0% during the 4th quarter. Man Group plc now owns 59,338 shares of the company’s stock worth $411,000 after purchasing an additional 15,059 shares during the last quarter. OMERS ADMINISTRATION Corp acquired a new stake in shares of Sensus Healthcare during the fourth quarter worth $381,000. Millennium Management LLC boosted its holdings in Sensus Healthcare by 256.6% in the 4th quarter. Millennium Management LLC now owns 85,329 shares of the company’s stock valued at $590,000 after purchasing an additional 61,403 shares in the last quarter. Finally, BNP Paribas Financial Markets acquired a new position in shares of Sensus Healthcare during the 4th quarter worth $47,000. Institutional investors and hedge funds own 25.30% of the company’s stock.

Sensus Healthcare Stock Up 5.4 %

NASDAQ:SRTS opened at $4.69 on Thursday. The stock has a market capitalization of $76.86 million, a PE ratio of 11.73 and a beta of 1.28. Sensus Healthcare has a 52 week low of $2.91 and a 52 week high of $9.33. The stock’s 50-day moving average price is $6.40 and its 200-day moving average price is $6.76.

Sensus Healthcare (NASDAQ:SRTS) last announced its earnings results on Wednesday, February 5th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.01). Sensus Healthcare had a return on equity of 12.60% and a net margin of 15.90%. Sell-side analysts expect that Sensus Healthcare will post 0.32 earnings per share for the current fiscal year.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.